Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report)’s share price was up 11.9% during mid-day trading on Thursday . The stock traded as high as $2.85 and last traded at $2.82. Approximately 326,018 shares traded hands during mid-day trading, a decline of 82% from the average daily volume of 1,794,341 shares. The stock had […]
EAM Investors LLC bought a new stake in Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 335,390 shares of the company’s stock, valued at approximately $1,060,000. EAM Investors LLC owned about 0.18% […]
EAM Investors LLC purchased a new position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Free Report) in the third quarter, Holdings Channel.com reports. The fund purchased 335,390 shares of the company’s stock, valued at approximately $1,060,000. Other large investors have also added to or reduced their stakes in the company. Swiss National Bank lifted its […]
Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) has received an average rating of “Moderate Buy” from the ten research firms that are currently covering the firm, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1 […]
Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the ten brokerages that are currently covering the firm, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average […]